Guangzhou LBP Medicine Science & Technology Co., Ltd.
SSE:688393.SS
28.33 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 95.147 | 67.682 | 90.911 | 217.676 | 635.271 | 85.698 | 74.959 | 73.733 | 96.12 | 30.925 | 53.156 | 22.253 |
| Short Term Investments
| 55.334 | 52.564 | 175.537 | 419.421 | 210.462 | 84.877 | -4.255 | -1.832 | 0 | 0.377 | 8.266 | 0.484 |
| Cash and Short Term Investments
| 150.481 | 120.246 | 266.447 | 637.097 | 845.733 | 170.575 | 74.959 | 73.733 | 96.12 | 31.302 | 61.422 | 22.737 |
| Net Receivables
| 247.21 | 245.251 | 239.035 | 211.944 | 185.465 | 169.425 | 169.88 | 147.969 | 0 | 101.103 | 76.962 | 68.896 |
| Inventory
| 84.439 | 74.972 | 63.074 | 40.568 | 25.046 | 20.544 | 23.64 | 19.097 | 16.106 | 24.853 | 11.989 | 4.857 |
| Other Current Assets
| 210.122 | 127.1 | 26.521 | 19.565 | 6.672 | 5.432 | 172.952 | 61.16 | 154.949 | 19.493 | 96.962 | 68.896 |
| Total Current Assets
| 692.252 | 567.57 | 595.076 | 909.175 | 1,062.916 | 365.975 | 328.752 | 306.848 | 267.175 | 176.751 | 170.373 | 96.49 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 298.533 | 314.378 | 327.035 | 276.65 | 193.759 | 133.485 | 111.081 | 80.212 | 62.149 | 49.337 | 13.28 | 8.975 |
| Goodwill
| 26.462 | 26.462 | 29.521 | 29.521 | 8.087 | 8.087 | 8.087 | 6.135 | 6.135 | 6.136 | 0.468 | 0.468 |
| Intangible Assets
| 32.653 | 22.637 | 7.247 | 5.853 | 5.772 | 5.922 | 6.065 | 6.592 | 6.877 | 0.227 | 0.228 | 0.114 |
| Goodwill and Intangible Assets
| 59.115 | 49.099 | 36.767 | 35.374 | 13.859 | 14.01 | 14.152 | 12.728 | 13.012 | 6.362 | 0.696 | 0.582 |
| Long Term Investments
| 122.827 | 140.624 | 5.535 | -353.674 | -202.962 | -77.377 | 11.902 | 1.979 | 2.402 | 20.872 | 5.089 | 3.702 |
| Tax Assets
| 35.63 | 27.611 | 19.038 | 12.693 | 12.382 | 11.999 | 9.801 | 6.462 | 6.282 | 3.809 | 2.482 | 1.652 |
| Other Non-Current Assets
| 154.374 | 300.65 | 409.332 | 485.467 | 212.296 | 89.869 | 0.877 | 3.832 | 6 | 0 | 0 | 0 |
| Total Non-Current Assets
| 670.478 | 832.361 | 797.707 | 456.509 | 229.334 | 171.986 | 147.812 | 105.211 | 89.846 | 80.38 | 21.546 | 14.911 |
| Total Assets
| 1,362.73 | 1,399.931 | 1,392.784 | 1,365.684 | 1,292.251 | 537.962 | 476.564 | 412.059 | 357.02 | 257.131 | 191.918 | 111.402 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 32.684 | 37.14 | 32.591 | 49.76 | 55.894 | 30.988 | 28.705 | 14.279 | 16.556 | 15.975 | 7.72 | 17.136 |
| Short Term Debt
| 7.298 | 26.646 | 14.305 | 9.538 | 0 | 0 | 0 | 0 | 0 | 10.279 | 0 | 0 |
| Tax Payables
| 4.051 | 6.525 | 7.936 | 5.693 | 8.904 | 7.008 | 6.296 | 4.46 | 5.058 | 2.818 | 3.014 | 8.882 |
| Deferred Revenue
| 0 | 6.821 | 12.715 | 46.177 | 3.968 | 3.559 | 3.322 | 3.055 | 0 | 6.951 | 0 | 0 |
| Other Current Liabilities
| 40.478 | 33.202 | 46.717 | 33.529 | 22.613 | 19.766 | 19.593 | 16.475 | 12.635 | 10.999 | 4.255 | 33.235 |
| Total Current Liabilities
| 84.512 | 110.335 | 114.264 | 106.839 | 87.411 | 57.762 | 54.595 | 35.214 | 34.249 | 40.071 | 14.988 | 59.254 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 1.65 | 5.185 | 7.241 | 2.853 | 1.773 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 27.535 | 0 | 28.938 | 29.888 | 30 | 30 | 30 | 30.15 | 1.324 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 13.374 | 14 | 16.083 | 13.345 | 7.256 | 5.572 | 2.654 | 0.414 | 0.507 | 0 | 0.03 | 0 |
| Other Non-Current Liabilities
| 3.917 | 32.107 | 32.858 | 32.923 | -1.773 | 0 | 0 | 0 | 0 | 2.06 | 3.579 | 4.06 |
| Total Non-Current Liabilities
| 46.476 | 51.291 | 56.183 | 49.121 | 37.256 | 35.572 | 32.654 | 30.564 | 1.831 | 2.06 | 3.608 | 4.06 |
| Total Liabilities
| 130.988 | 161.626 | 170.447 | 155.959 | 124.667 | 93.334 | 87.249 | 65.778 | 36.08 | 42.131 | 18.597 | 63.314 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 93.568 | 93.568 | 93.34 | 93.34 | 93.34 | 70 | 70 | 70 | 70 | 70 | 70 | 10 |
| Retained Earnings
| 381.373 | 374.117 | 347.616 | 333.419 | 287.148 | 210.031 | 160.102 | 122.044 | 99.43 | 90.938 | 55.958 | 30.817 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 61.135 | 50.73 | 36.005 | 28.376 | 156.689 | 150.775 | 0 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 780.8 | 795.927 | 788.024 | 777.244 | 751.478 | 134.873 | 156.689 | 150.775 | 146.05 | 42.191 | 42.191 | 7.27 |
| Total Shareholders Equity
| 1,255.74 | 1,263.611 | 1,228.605 | 1,204.003 | 1,167.971 | 443.28 | 386.791 | 342.819 | 315.48 | 211.753 | 173.322 | 48.087 |
| Total Equity
| 1,231.742 | 1,238.305 | 1,222.337 | 1,209.725 | 1,167.583 | 444.628 | 389.316 | 346.281 | 320.94 | 215 | 173.322 | 48.087 |
| Total Liabilities & Shareholders Equity
| 1,362.73 | 1,399.931 | 1,392.784 | 1,365.684 | 1,292.251 | 537.962 | 476.564 | 412.059 | 357.02 | 257.131 | 191.918 | 111.402 |